HIGHLIGHTS
- who: Albina Y. Ziganshina and collaborators from the Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Alexander Butlerov Institute of Chemistry, Kazan Federal University, Lobachevsky Str1/, have published the research work: Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells, in the Journal: Molecules 2023, 551 of /2023/
- what: The authors report on a new nanocarrier that was developed to deliver the anticancer drug doxorubicin to glioblastoma cells. The authors propose a simple procedure for synthesizing a nanocarrier for DOX The article discusses the creationand of the nanocarrier its . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.